MeVis Medical Solutions AG (LTS:0HI7) EV-to-EBIT : 7.94 (As of May. 26, 2024)

View and export this data going back to 2014. Start your Free Trial

What is MeVis Medical Solutions AG EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, MeVis Medical Solutions AG's Enterprise Value is €40.30 Mil. MeVis Medical Solutions AG's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was €5.08 Mil. Therefore, MeVis Medical Solutions AG's EV-to-EBIT for today is 7.94.

The historical rank and industry rank for MeVis Medical Solutions AG's EV-to-EBIT or its related term are showing as below:

LTS:0HI7' s EV-to-EBIT Range Over the Past 10 Years
Min: 2.5 Med: 6.93 Max: 12
Current: 7.94

During the past 13 years, the highest EV-to-EBIT of MeVis Medical Solutions AG was 12.00. The lowest was 2.50. And the median was 6.93.

LTS:0HI7's EV-to-EBIT is ranked better than
84.38% of 429 companies
in the Healthcare Providers & Services industry
Industry Median: 18.01 vs LTS:0HI7: 7.94

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. MeVis Medical Solutions AG's Enterprise Value for the quarter that ended in Sep. 2023 was €55.59 Mil. MeVis Medical Solutions AG's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was €5.08 Mil. MeVis Medical Solutions AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was 9.13%.

MeVis Medical Solutions AG EV-to-EBIT Historical Data

The historical data trend for MeVis Medical Solutions AG's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MeVis Medical Solutions AG EV-to-EBIT Chart

MeVis Medical Solutions AG Annual Data

Trend

Dec13

Dec14

Dec15

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

EV-to-EBIT

Get a 7-Day Free Trial

6.32

9.29

11.14

6.72

8.66

MeVis Medical Solutions AG Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EV-to-EBIT	Get a 7-Day Free Trial															11.14	-	6.72	-	8.66

Competitive Comparison of MeVis Medical Solutions AG's EV-to-EBIT

For the Health Information Services subindustry, MeVis Medical Solutions AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MeVis Medical Solutions AG's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MeVis Medical Solutions AG's EV-to-EBIT falls into.

MeVis Medical Solutions AG EV-to-EBIT Calculation

MeVis Medical Solutions AG's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	40.304	/	5.076
	=	7.94

MeVis Medical Solutions AG's current Enterprise Value is €40.30 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MeVis Medical Solutions AG's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was €5.08 Mil.

MeVis Medical Solutions AG (LTS:0HI7) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

MeVis Medical Solutions AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 )	=	EBIT	/	Enterprise Value (Q: Sep. 2023 )
	=	5.076	/	55.592
	=	9.13 %

MeVis Medical Solutions AG's Enterprise Value for the quarter that ended in Sep. 2023 was €55.59 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MeVis Medical Solutions AG's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was €5.08 Mil.

MeVis Medical Solutions AG EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of MeVis Medical Solutions AG's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

MeVis Medical Solutions AG (LTS:0HI7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MeVis Medical Solutions AG (LTS:0HI7) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

M3V:Germany

Address

Caroline-Herschel-Strasse 1, Bremen, DEU, 28359

Website

http://www.mevis.de

MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.

MeVis Medical Solutions AG (LTS:0HI7) Headlines

No Headlines